Jonathan C Hu, MD
Urology · Santa Cruz
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Dominican Hospital · El Camino Health · Sutter Maternity & Surgery Center of Santa Cruz. That is not proof they admit you there this week.
Plans that list them
8 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dominican HospitalSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative sepsis rate: 11.66 (8.02 to 15.3) · 412 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.169, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.489, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Sutter Maternity & Surgery Center of Santa CruzSanta Cruz, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 85% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Dominican Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative sepsis rateComplications and deaths | 11.66 (8.02 to 15.3) · 412 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.169 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.489 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0.06 to 1.95) · 1,248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.85 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.37 (94.33 to 174.41) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.8 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,973 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,510 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,695 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.44 to 5.4) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.76) · 436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.85 (0.4 to 3.29) · 1,474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.73 (3 to 14.46) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.17) · 6,336 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.937 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 212 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 505 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 45 · 237 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.5 · 594 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.9 · 510 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 473 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.8) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13 (9.4 to 17.7) · 126 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.4 to 15.4) · 1,585 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 390 cases | No different | Jan 2024 – Dec 2024 |
What patients said (774 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 32% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sutter Maternity & Surgery Center of Santa Cruz
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 59 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.5 to 1.52) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 63 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 118 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 116 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.56 to 4) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.41 (0 to 18.05) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.75 (2.52 to 10.98) · 102 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.94) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 30 cases | None | Apr 2023 – Mar 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (9.2 to 14.9) · 3,197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 506 cases | No different | Jan 2024 – Dec 2024 |
What patients said (203 patients answered, 24% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 87% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 69% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$122,848
Medicare paid this office $122,848 for 200 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 113 | $23,258 | $120 |
| New patient visit (45+ min) | 94 | $12,947 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 46 | $12,699 | $244 |
| Short return visit (20+ min) | 63 | $7,662 | $85 |
| Long return visit (40+ min) | 18 | $3,342 | $167 |
See all 16 services
| Return visit (30+ min) | 113 | $23,258 | $120 |
| New patient visit (45+ min) | 94 | $12,947 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 46 | $12,699 | $244 |
| Short return visit (20+ min) | 63 | $7,662 | $85 |
| Long return visit (40+ min) | 18 | $3,342 | $167 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 112 | $2,894 | $15 |
| Ultrasound scan of pelvic region through rectum | 20 | $2,732 | $137 |
| Simple bladder irrigation and/or instillation | 28 | $2,217 | $76 |
| Insertion of stent in ureter using an endoscope | 14 | $2,000 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,700 | $155 |
| Complete ultrasound scan behind abdominal cavity | 13 | $1,479 | $114 |
| Simple insertion of temporary bladder tube | 11 | $828 | $64 |
| Ultrasound measurement of bladder capacity after voiding | 43 | $646 | $12 |
| Limited ultrasound scan of pelvis | 13 | $570 | $44 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $371 | $22 |
| Urinalysis, manual test | 15 | $75 | $3 |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
200 Original Medicare patients in 2024. Average age 77 · Women 21% · Also on Medicaid 13% · Health risk score 1.27. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Diabetes 38% · Coronary heart disease 37% · Cancer 34% · Chronic kidney disease 33% · Atrial fibrillation 30% · Heart failure 20% · Depression 18% · Dementia 16% · COPD 13% · Stroke 9%.
The office billed $552,102, Medicare allowed $159,019 and paid $122,848; for 2,010 services of 91 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 200 | 2,010 | 77 | 1.27 | $552,102 | $122,848 |
| 2023 | 33 | 120 | 77 | 1.31 | $36,677 | $12,687 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$21,987
Pharmacies billed $21,987 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
327 generic and 22 brand-name prescriptions · $21,987 in drug cost · 96 antibiotic prescriptions to 61 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tamsulosin | 96 | $1,034 | $11 |
| Estradiol | 15 | $792 | $53 |
| Finasteride | 77 | $738 | $10 |
| Nitrofurantoin Mono-Macro | 21 | $193 | $9 |
| Sulfamethoxazole-Trimethoprim | 63 | $125 | $2 |
Year by year
| 2024 | 349 | 121 | None | 6% | $21,987 |
| 2023 | 262 | 126 | 7% (19) | None | $4,732 |
| 2022 | 331 | 180 | 8% (25) | 5% | $8,892 |
| 2021 | 184 | 104 | 8% (14) | 10% | $7,580 |
| 2020 | 124 | 63 | 11% (13) | 11% | $10,866 |
| 2019 | 77 | 50 | 33% (25) | None | $1,267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Tamsulosin | 70 | $710 | $10 |
| Finasteride | 27 | $319 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $135 | $11 |
| Sulfamethoxazole-Trimethoprim | 27 | $130 | $5 |
| Oxycodone | 19 | $48 | $3 |
| Cephalexin | 13 | $25 | $2 |
| Levofloxacin | 11 | $15 | $1 |
2022: 8 drugs
| Oxybutynin Chloride Er | 43 | $2,941 | $68 |
| Tamsulosin | 72 | $1,134 | $16 |
| Naloxone | 12 | $1,105 | $92 |
| Finasteride | 13 | $331 | $25 |
| Trospium Chloride | 16 | $236 | $15 |
| Sulfamethoxazole-Trimethoprim | 32 | $93 | $3 |
| Oxycodone | 24 | $56 | $2 |
| Levofloxacin | 21 | $38 | $2 |
2021: 4 drugs
| Tamsulosin | 37 | $359 | $10 |
| Nitrofurantoin Mono-Macro | 14 | $132 | $9 |
| Sulfamethoxazole-Trimethoprim | 30 | $120 | $4 |
| Oxycodone | 11 | $41 | $4 |
2020: 3 drugs
| Oxybutynin Chloride | 11 | $740 | $67 |
| Tamsulosin | 18 | $133 | $7 |
| Finasteride | 11 | $93 | $8 |
2019: 2 drugs
| Trospium Chloride | 12 | $173 | $14 |
| Oxycodone | 18 | $101 | $6 |
Money from drug and device companies
$1,239 in 2025
| 2025 | 16 | 47 | None | $1,239 |
| 2024 | 13 | 52 | None | $2,219 |
| 2023 | 9 | 15 | None | $2,609 |
| 2022 | 3 | 16 | None | $1,939 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Antares Pharma | Xyosted | $205 | 20 payments
|
| Sumitomo Pharma America | Gemtesa | $176 | 6 payments
|
| Medtronic | Interstim | $163 | 2 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $143 | 2 payments
|
| Abbvie | Botox | $118 | 4 payments
|
| Profound Medical | Tulsa-Pro | $108 | 1 payment
|
See all 47 published payments
| Medtronic | Meals · 2025-11-04 | Interstim | $144 |
| Sumitomo Pharma America | Meals · 2025-10-20 | Orgovyx | $28 |
| Teleflex | Meals · 2025-08-21 | Urolift | $49 |
| Valencia Technologies | Meals · 2025-08-04 | Ecoin Device Kit | $27 |
| AngioDynamics | Meals · 2025-07-29 | Nanoknife | $17 |
| Pfizer | Meals · 2025-07-14 | Xtandi | $29 |
| Pfizer | Meals · 2025-06-20 | Xtandi | $24 |
| Ferring Pharmaceuticals | Meals · 2025-06-13 | Adstiladrin | $27 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $18 |
| Abbvie | Meals · 2025-05-21 | Botox | $27 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $3 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $15 |
| Sumitomo Pharma America | Meals · 2025-05-08 | Gemtesa | $39 |
| Astellas Pharma US | Meals · 2025-05-08 | Xtandi | $24 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $2 |
| Sumitomo Pharma America | Meals · 2025-05-01 | Gemtesa | $38 |
| Abbvie | Meals · 2025-04-25 | Botox | $29 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $17 |
| Merck Sharp & Dohme | Meals · 2025-04-23 | Keytruda | $33 |
| Ferring Pharmaceuticals | Meals · 2025-04-23 | Adstiladrin | $116 |
| Verity Pharmaceuticals | Meals · 2025-04-21 | Tlando | $16 |
| Progenics Pharmaceuticals | Meals · 2025-04-15 | Pylarify | $24 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $16 |
| Profound Medical | Meals · 2025-04-07 | Tulsa-Pro | $108 |
| Pfizer | Meals · 2025-03-28 | Xtandi | $26 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $16 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $2 |
| Medtronic | Meals · 2025-03-13 | Rapidvac | $18 |
| Antares Pharma | Meals · 2025-03-12 | Xyosted | $16 |
| Immunitybio | Meals · 2025-03-07 | Anktiva | $23 |
| Sumitomo Pharma America | Education · 2025-03-06 | Gemtesa | $5 |
| Sumitomo Pharma America | Meals · 2025-03-03 | Gemtesa | $34 |
| Abbvie | Meals · 2025-02-28 | Botox | $31 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $15 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-02-05 | Xyosted | $19 |
| Procept Biorobotics | Meals · 2025-02-04 | Aquabeam Robotic System | $34 |
| Sumitomo Pharma America | Meals · 2025-01-29 | Gemtesa | $31 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $18 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $2 |
| Abbvie | Meals · 2025-01-10 | Botox | $32 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $18 |
See earlier years (2024, 2023, 2022)
2024: $2,219
| Edap Technomed | None | $1,210 | 8 payments
|
| Sumitomo Pharma America | Gemtesa | $289 | 10 payments
|
| Antares Pharma | Xyosted | $254 | 18 payments
|
| AngioDynamics | Nanoknife | $134 | 3 payments
|
| Medtronic | Interstim | $94 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $57 | 2 payments
|
| Abbvie | Lupron Depot | $39 | 2 payments
|
| Immunitybio | Anktiva | $34 | 1 payment
|
| Urogen Pharma | Jelmyto | $26 | 1 payment
|
| Axonics | Axonics | $24 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $22 | 1 payment
|
| Coloplast | Titan | $19 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $17 | 1 payment
|
2023: $2,609
| Intuitive Surgical | Da Vinci Surgical System | $2,061 | 2 payments
|
| Dornier MedTech America | Dornier Medtech | $202 | 1 payment
|
| Agiliti Surgical | Sonablate | $103 | 2 payments
|
| Boston Scientific | Lithoclast | $64 | 2 payments
|
| Janssen Biotech | Erleada | $62 | 3 payments
|
| Supernus Pharmaceuticals | Xyosted | $42 | 2 payments
|
| Amgen | Xgeva | $33 | 1 payment
|
| Pfizer | Xtandi | $21 | 1 payment
|
| Medtronic | Interstim | $20 | 1 payment
|
2022: $1,939
| Boston Scientific | General - Therapies | $1,530 | 12 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $386 | 3 payments
|
| Allergan | Botox | $23 | 1 payment
|
Professional record
- NPI
- 1871097956
- Licence
- CA FH8788563
- Trained
- Oakland Univ, William Beaumont School of Medicine, 2018
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2911 Chanticleer Ave, Santa Cruz, CA, 95065
- NPI first listed
- 2018-03-22
- NPI last updated
- 2026-07-16
- NPI record certified
- 2026-07-16
This is when the NPI record was last certified, not a medical board exam.